DEBUNKED: The Sunday Telegraph | Meningococcal B vaccine rejected for inclusion on free schedule, 22nd Dec ‘19

Original artcle here. Here we respond to some of the points made in Jane Hansen’s article where she strongly implies that Bexsero should be placed on the NIP schedule. 1. “The vaccine Bexsero has been rejected for the fourth time by the Pharmaceutical Benefits Advisory Committee, which cited cost as the main reason.” The above… [Read More]